Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetic neuropathy and the need for effective treatment methods
5.1.1.2. Increasing awareness pertaining to diagnosis & treatment of diabetes
5.1.1.3. Government initiatives for the management of diabetic neuropathy
5.1.2. Restraints
5.1.2.1. High failure rate in clinical trials and high cost of diabetic neuropathy treatment
5.1.3. Opportunities
5.1.3.1. Widening diabetic neuropathy research areas
5.1.3.2. Development of advanced drug delivery systems
5.1.4. Challenges
5.1.4.1. Complications associated with diabetic neuropathy treatment
5.2. Market Segmentation Analysis
5.2.1. Treatment Type: Wide use of drugs for pharmacological treatment in diabetic neuropathy for alleviating pain and stabilizing nerve function
5.2.2. Disorder Type: Preference for diabetic neuropathy due to increasing prevalence of peripheral neuropathy
5.2.3. Distribution channel: Emergence of online pharmacies as a convenient distribution channel for medications prescribed for diabetic neuropathy management
5.3. Market Trend Analysis
5.3.1. Ongoing research for the development of novel treatments and rise in approvals for diabetic neuropathy management systems in the Americas
5.3.2. Increasing prevalence of diabetes and emerging start-ups focused on developing diabetic neuropathy treatments and devices in the APAC region
5.3.3. Supportive government initiatives to improve diabetes disease treatment and care in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis

6. Diabetic Neuropathy Market, by Treatment Type
6.1. Introduction
6.2. Drugs
6.3. Physiotherapy

7. Diabetic Neuropathy Market, by Disorder Type
7.1. Introduction
7.2. Autonomic Neuropathy
7.3. Focal Neuropathy
7.4. Peripheral Neuropathy
7.5. Proximal Neuropathy

8. Diabetic Neuropathy Market, by Distribution channel
8.1. Introduction
8.2. Clinics
8.3. Hospitals
8.4. Online Pharmacy
8.5. Retail Pharmacy

9. Americas Diabetic Neuropathy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Diabetic Neuropathy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Diabetic Neuropathy Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Neuralace Medical Completes Enrollment of Painful Diabetic Neuropathy Label Expansion Study (AT-PDN) Paving the Way for FDA Clearance and a Breakthrough, Non-invasive Treatment for Diabetes related Neuropathic Pain
12.3.2. GBP 1.4 million Awarded to Create early test for Diabetic Peripheral Neuropathy
12.3.3. Horizon Therapeutics PLC announced FDA approval of an update to the indication language for TEPEZZA (teprotumumab-trbw) to specify its use in thyroid eye disease (TED) patients regardless of disease activity or duration
12.3.4. Praetego awarded USD 300,000 by National Eye Institute to advance novel oral drug for diabetic retinopathy
12.3.5. Abbott, Medtronic, and Nevro are developing SCS therapies to treat peripheral neuropathy treatment

a diabetic for diabetic
12.3.6. NeuroMetrix launched peripheral neuropathy test DPNCheck 2.0
12.3.7. Tandem Diabetes Care completed acquisition of insulin pump maker AMF Medical
12.3.8. P&G Health, IDF partnered to address Peripheral Neuropathy in people with diabetes
12.3.9. Glenmark Pharma launched drug for diabetic patients with comorbidities
12.3.10. Regenacy Pharmaceuticals announced the completion of enrollment for phase 2 Study in diabetic peripheral neuropathy & USD 9.3 million series B financing
12.3.11. Medtech startup Yostra Labs raised Rs 4Cr in a Seed round to help patients suffering from chronic disease
12.3.12. FDA Clears PENS Device for pain related to diabetic peripheral neuropathy
12.3.13. FDA cleared Medtronic’s neurostimulator for diabetic peripheral neuropathy pain
12.3.14. The RMH partnered with Australian Centre for Accelerating Diabetes Innovations
12.3.15. Withings acquired Devicemaker Impeto Medical

13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio



List of Figures

FIGURE 1. DIABETIC NEUROPATHY MARKET RESEARCH PROCESS
FIGURE 2. DIABETIC NEUROPATHY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DIABETIC NEUROPATHY MARKET DYNAMICS
FIGURE 7. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DIABETIC NEUROPATHY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. DIABETIC NEUROPATHY MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. DIABETIC NEUROPATHY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY OPIOIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY GABAPENTIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY GABAPENTIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PREGABALIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PREGABALIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TOPIRAMATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TOPIRAMATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY SEROTONIN & NOREPINEPHRINE REUPTAKE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY SEROTONIN & NOREPINEPHRINE REUPTAKE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY SSRIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY SSRIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TCAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY TCAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY AUTONOMIC NEUROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY AUTONOMIC NEUROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY FOCAL NEUROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY FOCAL NEUROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PERIPHERAL NEUROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PERIPHERAL NEUROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PROXIMAL NEUROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY PROXIMAL NEUROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL DIABETIC NEUROPATHY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 110. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 111. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 112. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 113. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 114. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 115. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 116. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 117. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 118. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 119. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 120. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 121. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. CANADA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 124. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 125. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 126. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 127. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 128. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 129. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 130. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 131. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 132. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 133. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 134. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 135. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 136. MEXICO DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES DIABETIC NEUROPATHY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC DIABETIC NEUROPATHY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 177. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 178. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 184. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 185. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 186. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 187. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 188. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 189. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 190. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 191. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 192. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 193. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 194. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 195. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. CHINA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 198. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 199. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 200. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 201. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 202. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 203. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 204. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 205. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 206. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 207. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 208. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 209. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 210. INDIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 219. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 220. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 226. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 227. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 228. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 229. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 230. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 231. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 232. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 233. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 234. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 235. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 236. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 237. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. JAPAN DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 247. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 248. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 261. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 262. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 267. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 268. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 275. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 276. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 282. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 289. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 290. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 295. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 296. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY ANALGESICS, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTICONVULSANTS, 2024-2030 (USD MILLION)
TABLE 303. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2018-2023 (USD MILLION)
TABLE 304. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY ANTIDEPRESSANT, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN DIABETIC NEUROPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 309. THAILAND DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 310. THAILAND DIABETIC NEUROPATHY MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 311. THAILAND DIABETIC NEUROPATHY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 312. THAIL